Base de dados : HANSEN
Pesquisa : PENTOXIFILINA [Descritor de assunto]
Referências encontradas : 9 [refinar]
Mostrando: 1 .. 9   no formato [Detalhado]

página 1 de 1

  1 / 9 HANSEN  
              next record last record
seleciona
para imprimir
Texto Completo-en
Id:26740
Autor:Park, Eunkyue; Schuller-Levis, Georgia; Park, Seung Yong; Jia, Jun Hua; Levis, William R.
Título:Pentoxifylline downregulares nitric oxide and tumor necrosis factor-a induced by mycobacterial lipoarabinomannan in a macrophage cell line.
Fonte:Int. J. Lepr;69(3):225-233, Sept., 2001. ilus, tab, graf.
Resumo:Pentoxifylline (PTX), a phosphodiesterase inhibitor, is known to downregulate tumor necrosis factor-alpha (TNF-alpha) secretion induced by lipopolysacchride (LPS) and gamma interferon (IFN-gamma). We have had limited success in treating leprosy reactions, including erythema nodosum leprosum (ENL), in which TNF-alpha has been identified as a major proinflammatory cytokine. PTX inhibited production of NO (IC50 approximately equal to 1.0 mg/ml) and TNF-alpha (IC50 approximately equal to 0.05 mg/ml) in a dose-dependent fashion. As little as 0.5 mg/ml of PTX decreased NO production and 0.01 mg/ml of PTX inhibited TNF-alpha production. Western blot analyses demonstrated that iNOS was suppressed by PTX. Northern blot analyses showed significant reduction of TNF-alpha mRNA. We conclude that PTX is an effective inhibitor of lipoarabinomannan (LAM)-induced TNF-alpha production at both the product and transcriptional levels in our macrophage cell line. PTX also showed moderate inhibition of NO at the product level as well as translation of iNOS. (AU)^ien.
Descritores:Pentoxifilina/sint quim
Pentoxifilina/imunol
Fator de Necrose Tumoral alfa/sint quim
Fator de Necrose Tumoral alfa/imunol
Macrófagos/imunol
Meio Eletrônico:http://hansen.bvs.ilsl.br/textoc/revistas/intjlepr/2001/pdf/v69n3/v69n3a07.pdf - en.
Localização:BR191.1


  2 / 9 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Texto Completo-en
Id:26603
Autor:Dawlah, Zubaer M; Cabrera, Aloys; Ahern, Kathleen; Levis, William R.
Título:A phase 2 open trial of pentoxifylline for the treatment of leprosy reactions.
Fonte:Int. J. Lepr;70(1):38-43, Mar.,2002. tab.
Descritores:Pentoxifilina/imunol
Pentoxifilina/uso terap
Hanseníase/imunol
Hanseníase/fisiopatol
Meio Eletrônico:http://hansen.bvs.ilsl.br/textoc/revistas/intjlepr/2002/pdf/v70n1/v70n1cor04.pdf - en.
Localização:BR191.1


  3 / 9 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:18990
Autor:Carsalade, Georges-Yves de; Achirafi, Aboubacar; Flageul, Béatrice
Título:Pentoxifylline in the treatment of erythema nodosum leprosum
..-
Fonte:s.l; s.n; Jan. 2003. 5 p. tab.
Resumo:Erythema nodosum leprosum (ENL) is a well-known serious complication affecting 10 per cent of lepromatous multibacillary leprosy patients. In the chronic form, its morbidity may be considerable. Thalidomide and systemic steroids are the two current effective drugs for the management of ENL. However, their use in endemic countries is often difficult and hazardous, and a search for new therapies is needed. We report our experience on the effects of pentoxifylline, a methylxanthine derivative, which has recently been suggested as a possible effective treatment for ENL attacks. (AU).
Descritores:ERITEMA NODOSO/quimioter
ERITEMA NODOSO/patol
ESQUEMA DE MEDICACAO
ADMINISTRACAO ORAL
HANSENOSTATICOS/admin
HANSENOSTATICOS/uso terap
HANSENIASE VIRCHOWIANA/quimioter
HANSENIASE VIRCHOWIANA/patol
PENTOXIFILINA/admin
PENTOXIFILINA/uso terap
INDICE DE GRAVIDADE DE DOENCA
RESULTADO DE TRATAMENTO
Limites:HUMANO
MASCULINO
FEMININO
ADULTO
ADOLESCENTE
Meio Eletrônico: - .
Localização:BR191.1; 09150/s


  4 / 9 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:18946
Autor:Teles, Rosane M. B; Moraes, Milton O; Geraldo, Natasha T. R; Salles, Ana M; Sarno, Euzenir N; Sampaio, Elizabeth P
Título:Differential TNFalpha mRNA regulation detected in the epidermis of leprosy patients
..-
Fonte:s.l; s.n; 2002. 8 p. ilus, tab, graf.
Resumo:The epidermis is an important site of the immunoinflammatory response in the skin. In the present study, the expression of cytokine and ICAM-1 (intercellular adhesion molecule-1) genes was evaluated by RT-PCR in the epidermis isolated from biopsies from 25 reactional leprosy patients. TNFalpha and IL-6 mRNAs were detected in all individuals during the reactional state (reversal reaction or erythema nodosum leprosum), IL-8 message was detected in 66.6 per cent and 62.5 per cent of the patients, IL-12 mRNA was present in 91.6 per cent and 62.5 per cent and ICAM-1 in 100 per cent and 71.4 per cent, respectively. In addition, when skin biopsies were obtained from the same patients before and during the reactional episode, an enhancement in cytokine mRNA, but not in ICAM-1 mRNA, was observed. Seven patients were also evaluated at the onset of reaction and during antiinflammatory treatment. In contrast to a preferential decrease in the TNFalpha gene detected in the dermis, during the treatment phase, persistent/enhanced TNFalpha mRNA expression was detected in the epidermis in six out of the seven patients assessed. This peculiar pattern of expression might reflect a differential impact that in vivo antiinflammatory therapy has on the epidermis. The present findings indicate that the epidermis plays an important role in the local inflammatory response in leprosy and that the profile of response detected in the epidermis during the reactions may be regulated differently from that in the dermis. (AU).
Descritores:CITOCINAS/genet
CITOCINAS/metab
ANTIINFLAMATORIOS ESTERÓIDES/uso terap
DERME/metab
HANSENOSTATICOS/uso terap
EPIDERME/metab
MOLECULA 1 DE ADESAO INTERCELULAR/genet
MOLECULA 1 DE ADESAO INTERCELULAR/metab
HANSENIASE/quimioter
HANSENIASE/metab
PENTOXIFILINA/uso terap
ANTIINFLAMATORIOS/uso terap
RNA MENSAGEIRO/metab
TALIDOMIDA/uso terap
PREDNISONA/uso terap
FATOR DE NECROSE TUMORAL/genet
FATOR DE NECROSE TUMORAL/metab
Limites:HUMANO
MASCULINO
FEMININO
ADULTO
MEIA-IDADE
IDOSO
SUPPORT, NON-U.S. GOV'T
Meio Eletrônico: - .
Localização:BR191.1; 09157/s


  5 / 9 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:18498
Autor:Hernandez, M. O; Neves Junior, I; Sales, J. S; Carvalho, D. S; Sarno, E. N; Sampaio, E. P
Título:Induction of apoptosis in monocytes by Mycobacterium leprae in vitro: a possible role for tumour necrosis factor-alpha
..-
Fonte:s.l; s.n; 2003. 9 p. graf.
Resumo:A diverse range of infectious organisms, including mycobacteria, have been reported to induce cell death in vivo and in vitro. Although morphological features of apoptosis have been identified in leprosy lesions, it has not yet been determined whether Mycobacterium leprae modulates programmed cell death. For that purpose, peripheral blood mononuclear cells obtained from leprosy patients were stimulated with different concentrations of this pathogen. Following analysis by flow cytometry on 7AAD/CD14+ cells, it was observed that M. leprae induced apoptosis of monocyte-derived macrophages in a dose-dependent manner in both leprosy patients and healthy individuals, but still with lower efficiency as compared to M. tuberculosis. Expression of tumour necrosis factor-alpha (TNF-alpha), Bax-alpha, Bak mRNA and TNF-alpha protein was also detected in these cultures; in addition, an enhancement in the rate of apoptotic cells (and of TNF-alpha release) was noted when interferon-gamma was added to the wells. On the other hand, incubation of the cells with pentoxifylline impaired mycobacterium-induced cell death, the secretion of TNF-alpha, and gene expression in vitro. In addition, diminished bacterial entry decreased both TNF-alpha levels and the death of CD14+ cells, albeit to a different extent. When investigating leprosy reactions, an enhanced rate of spontaneous apoptosis was detected as compared to the unreactive lepromatous patients. The results demonstrated that M. leprae can lead to apoptosis of macrophages through a mechanism that could be at least partially related to the expression of pro-apoptotic members of the Bcl-2 protein family and of TNF-alpha. Moreover, while phagocytosis may be necessary, it seems not to be crucial to the induction of cell death by the mycobacteria. (AU).
Descritores:APOPTOSE/ef drogas
APOPTOSE/imunol
CELULAS CULTIVADAS
REGULACAO DA EXPRESSÃO GÊNICA
INTERFERON TIPO II/farmacol
HANSENIASE/imunol
PROTEINAS DE MEMBRANA/genet
MONOCITOS/imunol
MONOCITOS/patol
MYCOBACTERIUM LEPRAE/imunol
PENTOXIFILINA/farmacol
FAGOCITOSE/imunol
PROTEINAS PROTO-ONCOGÊNICAS/genet
FATOR DE NECROSE TUMORAL/imunol
Limites:HUMANO
MASCULINO
FEMININO
ADULTO
MEIA-IDADE
IDOSO
SUPPORT, NON-U.S. GOV'T
Meio Eletrônico: - .
Localização:BR191.1; 09128/s


  6 / 9 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:15323
Autor:Welsh, Oliverio; Gomes, Minerva; Mancias, Cecilia; Ibarra-Leal, Sara; Millikan, Larry E
Título:A new therapeutic approach to type II leprosy reaction
..-
Fonte:s.l; s.n; 1999. 3 p. ilus.
Descritores:CLOFAZIMINA
QUIMIOTERAPIA COMBINADA
ERITEMA NODOSO
ERITEMA NODOSO
LEPROSTATICOS
HANSENIASE LEPROMATOSA
HANSENIASE LEPROMATOSA
PENTOXIFILINA
Localização:BR191.1; 07244/s


  7 / 9 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:14145
Autor:Singh, Megha; Kumaravel, M
Título:Sequential analysis of erythrocyte aggregation in health and diseases
..-
Fonte:s.l; s.n; 1997. 6 p. tab, graf.
Descritores:AGREGAÇAO ERITROCITICA
HEMORREOLOGIA
LASERS
HANSENIASE
PENTOXIFILINA
FATORES DE TEMPO
Localização:BR191.1. 8828/s


  8 / 9 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:14035
Autor:Sampaio, E. P; Moraes, M. O; Nery, J. A. C; Santos, A. R; Matos, H. C; Sarno, E. N
Título:Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-a) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL)
..-
Fonte:s.l; s.n; 1998. 9 p. tab, graf.
Descritores:HANSENIASE LEPROMATOSA
HANSENIASE LEPROMATOSA
ERITEMA NODOSO
ERITEMA NODOSO
PENTOXIFILINA
INIBIDORES DE FOSFODIESTERASE
REAÇAO EM CADEIA POR POLIMERASE
RNA MENSAGEIRO
FATOR DE NECROSE DE TUMOR
Localização:BR191.1; 07001/s


  9 / 9 HANSEN  
              first record previous record
seleciona
para imprimir
Id:11614
Autor:Valentini, Attilio; Nery, Jose A. C; Salles, Ana Maria; Vieira, Lelia M. M; Sarno, Euzenir N
Título:Edema na hanseniase: aspectos clinicos e terapeuticos
Edema in leprosy: clinical and therapeutical aspects-
Fonte:s.l; s.n; 1999. 8 p. tab.
Descritores:HANSENIASE
EDEMA
EDEMA
CORTICOSTEROIDES
TALIDOMIDA
PENTOXIFILINA
FATOR DE NECROSE DE TUMOR
INTERLEUCINA-1
Localização:BR191.1; 05963/s



página 1 de 1
   


Refinar a pesquisa
  Base de dados : HANSEN Formulário avançado   
Pesquisar por : Formulário livre   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6.1 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information